Evaluate the Safety and Efficacy of Tafasitamab Combined With Lenalidomide in Patients With Relapsed or Refractory DLBCL

Abroad (travel likely)RecruitingPHASE2

Conditions

DLBCL

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The First Afflicated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
Contact: Study coordinator (Jie Jin) · jiej0503@163.com · 0571-87236114

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma

Non-Hodgkin's Lymphoma · Diffuse Large B-Cell Lymphoma · DLBCL

Abroad (travel likely)RecruitingPHASE2

Bethesda, United States

Hypofractionation Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse B-cell Lymphoma With Baseline High Tumor Burden

Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) · Lymphoma

Abroad (travel likely)RecruitingPHASE2

Wuhan, China

Multicenter, Single-Arm Exploratory Phase I Clinical Study (Assessment of Safety and Efficacy) of Fully Human BAFF-R Chimeric Antigen Receptor T-Cell Injection in Relapsed/Refractory BAFF-R-Positive B-Cell Lymphoma

DLBCL · CLL · FL

Abroad (travel likely)RecruitingPHASE1, PHASE2

Tianjin, China

Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma

Lymphoma · Waldenström Macroglobulinemia (WM) · DLBCL - Diffuse Large B Cell Lymphoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Richmond, Australia · Nedlands, Australia